AbbVie Inc. Executive Compensation Details Revealed

Ticker: ABBV · Form: DEF 14A · Filed: 2024-03-18T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, DEF14A, annual-filing

Related Tickers: ABBV

TL;DR

AbbVie's 2023 exec pay details are out - pensions & stock awards for top brass.

AI Summary

AbbVie Inc. filed its DEF 14A on March 18, 2024, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on pension adjustments and equity awards for its PEO and Non-PEO/NEO members, with data spanning from 2020 to 2023.

Why It Matters

This filing provides transparency into how AbbVie Inc. compensates its top executives, which can influence investor decisions and employee morale.

Risk Assessment

Risk Level: low — This is a routine annual filing providing compensation details, not indicating new risks.

Key Players & Entities

AbbVie Inc. (company) — Filer of the DEF 14A
March 18, 2024 (date) — Filing date of the DEF 14A
December 31, 2023 (date) — Fiscal year end for compensation data

FAQ

What is the primary purpose of this DEF 14A filing for AbbVie Inc.?

The primary purpose is to provide detailed information regarding the compensation of AbbVie Inc.'s top executives for the fiscal year ending December 31, 2023.

When was this DEF 14A filing submitted to the SEC?

This DEF 14A filing was submitted to the SEC on March 18, 2024.

What specific compensation components are detailed in the filing for the fiscal year 2023?

The filing details pension adjustments and equity awards for both PEO (Principal Executive Officer) and Non-PEO/NEO (Non-Principal Executive Officer/Non-Executive Officer) members.

What is the fiscal year end date for which the compensation data is reported?

The compensation data reported in this filing is for the fiscal year ending December 31, 2023.

What is AbbVie Inc.'s standard industrial classification code?

AbbVie Inc.'s standard industrial classification code is 2834, for Pharmaceutical Preparations.

From the Filing

0001558370-24-003496.txt : 20240318 0001558370-24-003496.hdr.sgml : 20240318 20240318161549 ACCESSION NUMBER: 0001558370-24-003496 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20240503 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 24759224 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 DEF 14A 1 abbv-20240503xdef14a.htm DEF 14A 0001551152 false DEF 14A 0001551152 7 2023-01-01 2023-12-31 0001551152 6 2023-01-01 2023-12-31 0001551152 5 2023-01-01 2023-12-31 0001551152 4 2023-01-01 2023-12-31 0001551152 3 2023-01-01 2023-12-31 0001551152 2 2023-01-01 2023-12-31 0001551152 1 2023-01-01 2023-12-31 0001551152 2022-01-01 2022-12-31 0001551152 2021-01-01 2021-12-31 0001551152 2020-01-01 2020-12-31 0001551152 abbv:PensionAdjustmentsServiceCostMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:PensionAdjustmentsServiceCostMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 abbv:PensionAdjustmentsPensionValueInSummaryCompensationTableMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:PensionAdjustmentsPensionValueInSummaryCompensationTableMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 abbv:PensionAdjustmentsMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:PensionAdjustmentsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsValueInCompensationTableForApplicableYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001551152 abbv:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001551152 2023-01-01 2023-12-31 0001551152 ecd:PeoMember 2023-01-01 2023-12-31 0001551152 ecd:NonPeoNeoMember 2023-01-01 2023-12-31 iso4217:USD iso4217:USD xbrli:shares Table of Contents  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ⌧ Filed by a Party other than the Registrant ◻ Check the appropriate box: ◻ Preliminary Proxy Statement ◻ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ⌧ Definitive Proxy Statement ◻ Definitive Additional Materials ◻ Soliciting Material under §240.14a-12   AbbVie Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement